10,748 Shares in Cigna Group $CI Acquired by Key Financial Inc

Key Financial Inc bought a new position in Cigna Group (NYSE:CI) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 10,748 shares of the health services provider’s stock, valued at approximately $3,553,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CI. Valeo Financial Advisors LLC boosted its holdings in Cigna Group by 86,071.1% in the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after purchasing an additional 3,471,249 shares during the last quarter. Nuveen LLC purchased a new stake in Cigna Group in the first quarter worth approximately $727,905,000. Price T Rowe Associates Inc. MD boosted its holdings in Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after purchasing an additional 1,094,327 shares during the last quarter. GQG Partners LLC boosted its holdings in Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after purchasing an additional 865,092 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its holdings in Cigna Group by 38.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after purchasing an additional 457,052 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Up 6.3%

Shares of CI stock opened at $259.76 on Tuesday. The company has a market capitalization of $69.34 billion, a price-to-earnings ratio of 14.18, a PEG ratio of 0.88 and a beta of 0.45. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company’s fifty day moving average price is $296.37 and its 200-day moving average price is $305.30. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, beating the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company’s revenue was up 9.5% on a year-over-year basis. During the same period last year, the firm earned $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be given a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.64%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on CI shares. Barclays dropped their price target on shares of Cigna Group from $383.00 to $300.00 and set an “overweight” rating on the stock in a research note on Friday. Guggenheim dropped their price target on shares of Cigna Group from $350.00 to $309.00 in a research note on Friday. Truist Financial dropped their price target on shares of Cigna Group from $375.00 to $310.00 in a research note on Friday. Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a research note on Friday, October 3rd. Finally, The Goldman Sachs Group started coverage on shares of Cigna Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $370.00 price target on the stock. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average price target of $348.70.

Insider Activity

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO David Cordani purchased 4,134 shares of Cigna Group stock in a transaction on Monday, November 3rd. The stock was bought at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the acquisition, the chief executive officer owned 157,935 shares in the company, valued at $38,201,317.80. The trade was a 2.69% increase in their position. The SEC filing for this purchase provides additional information. Insiders own 0.70% of the company’s stock.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.